Read news as it happens
Create a Rediffmail account
J&J to pay Rs 25 lakh each to 67 victims of faulty ASR hip implants
Of the 289 faulty hip implant victims identified, 93 patients had undergone revision surgeries. The company, however,...
Indian pharma exports report double-digit growth after 3 yrs
The only category of pharmaceuticals that showed a negative growth in exports this time was herbal products, exports...
Govt reduces prices of 390 cancer drugs up to 87%
This move is expected to benefit 22 lakh cancer patients in the country.
Post SC ruling, Piramal readies big plans for Saridon
This ruling means that we will continue to invest in the brand and we will also look at launching line extensions...
Why Indian pharma cos are gung-ho about the US mkt
While companies continue to face regulatory pressure leading to higher costs, they see an uptick from the launch of...
MNC pharma cos may be afflicted by pneumonia virus
Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.
PIO entrepreneur to bring smart glasses to India
OXSIGHT, founded in 2016 to create wearable technology devices based on how the brain manages visual information,...
2 reasons why drug sales are in poor health
Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind...
Why cold wave across US is good news for Indian drug cos
Companies such as Cadila Healthcare, Lupin, and Natco, which sell generic versions of flu medication in the US...
Kiran Mazumdar-Shaw fined by Infy for 'insider trading'
The penalty collected from Mazumdar-Shaw will be donated to a charitable organisation of her choice.
Office email App
© 2019 Rediff.com